Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management
Open Access
- 1 March 1997
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 81 (3) , 228-233
- https://doi.org/10.1136/bjo.81.3.228
Abstract
AIM Many growth factors are implicated in proliferative diabetic retinopathy (PDR). It was decided to test the hypothesis that no one factor is predominant but that a regular profile of levels of different growth factors might be operating, and that the profile might differ according to whether or not insulin therapy was part of the patient’s glycaemic management. The levels of several growth factors in vitrectomy samples were therefore determined from diabetic patients with tractional, non-haemorrhagic sequelae of PDR and these levels were correlated with (a) each other (growth factor profile), (b) neovascular activity, and (c) the method of glycaemic management (insulin treated (IT) or non-insulin treated (NIT)). METHODS 72 samples of vitreous were obtained from either diabetic patients with PDR (n = 51) or non-diabetic (control) patients (n = 21). Levels of bFGF, IGF-I, EGF, and insulin were determined by radioimmunoassay; levels of TGF-β2 by ELISA; and levels of IGF-I binding protein by western ligand blotting. The data were analysed using appropriate statistics. RESULTS There was no regular growth factor profile. bFGF levels were significantly greater in vitreous from NIT patients compared with IT patients and controls. The highest levels of bFGF were found in NIT patients with actively vascularised membranes. TGF-β2 levels were significantly greater in vitreous from IT patients compared with NIT patients and controls The highest levels of TGF-β2 were found in IT patients with actively vascularised membranes. IGF-I levels were significantly greater in diabetics (irrespective of insulin treatment) than non-diabetics and the highest levels of IGF-I were found in IT patients with actively vascularised membranes. A 34 kDa IGFBP was the predominant IGFBP identified in vitreous and was found to be elevated in diabetics patients. CONCLUSION In PDR there is a correlation between intravitreal growth factor levels and both disease state (whether active or fibrotic) and method of glycaemic management.Keywords
This publication has 27 references indexed in Scilit:
- The role of growth factors in the development of diabetic retinopathyMetabolism, 1995
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995
- Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid.1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Detection of Vascular Endothelial Growth Factor Messenger RNA and Vascular Endothelial Growth Factor-like Activity in Proliferative Diabetic RetinopathyArchives of Ophthalmology (1950), 1994
- Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy.British Journal of Ophthalmology, 1994
- Production of IGF-I and IGF binding proteins by retinal cells in vitro.British Journal of Ophthalmology, 1994
- Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabeticsCurrent Eye Research, 1994
- Peptide growth factors are multifunctionalNature, 1988
- ANGIOGENIC FACTOR IN HUMAN OCULAR FLUIDThe Lancet, 1985